The rising impact of biomarkers in early clinical development
Drug Target Review
APRIL 7, 2025
The context of use (COU) of biomarker assays must be firmly established, clearly and comprehensively citing how they should be used, and the regulated product development and review-related purpose of that use. That requires taking every possible step to characterise dosage and physiological responses.
Let's personalize your content